New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection

Título

New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection

Autor

Haixia Sun, Guohui Wan, Xian-Zhang Bu, Shijia Yan

Fecha

2020

Materia

Pandemic, drug screening, integrin, RGD, SARS-CoV-2, COVID-19

Identificador

DOI: 10.3389/fphar.2020.00912

Fuente

Frontiers in Pharmacology

Editor

Frontiers Media S.A.

Cobertura

Therapeutics. Pharmacology

Archivos

https://socictopen.socict.org/files/to_import/pdfs/5115318.pdf

Colección

Coronavirus

Citación

Haixia Sun, Guohui Wan, Xian-Zhang Bu, Shijia Yan, “New Strategy for COVID-19: An Evolutionary Role for RGD Motif in SARS-CoV-2 and Potential Inhibitors for Virus Infection,” SOCICT Open, consulta 19 de abril de 2026, https://socictopen.socict.org/items/show/3906.

Formatos de Salida

Position: 11158 (24 views)